Arni compositions directed against the activin receptor a type 1c (acvr1c) and methods
CL202600785A1Pending Publication Date: 2026-08-07ALNYLAM PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202600785
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-19
- Filing Date
- 2026-03-17
- Publication Date
- 2026-08-07
Abstract
This disclosure describes RNAi agents, e.g., double-stranded RNA (dsRNA) agents, directed against an activin A receptor type 1C (ACVR1C) gene. The disclosure also relates to methods of using such RNAi agents to inhibit the expression of an ACVR1C gene and to methods of preventing and treating a disorder associated with ACVR1C, e.g., a metabolic disorder such as metabolic syndrome.
Need to check novelty before this filing date? Find Prior Art